Interventional Oncology: On the Forefront of Cancer Care and Innovation
RSNA News
The RSNA News article Interventional Oncology: On the Forefront of Cancer Care and Innovation highlights the growing importance of interventional oncology and emphasizes how the International Accreditation System for Interventional Oncology Services (IASIOS) is helping to set global standards for quality and safety. Since its launch in 2021, IASIOS has accredited more than 30 centres worldwide, with the Mallinckrodt Institute of Radiology becoming the first in the U.S. to achieve accreditation. By standardizing practice, improving safety protocols, and enhancing credibility with patients and physicians, IASIOS is raising the profile of interventional oncology and supporting its recognition as a key pillar of modern cancer care. Read the full article to learn more about how IASIOS is driving this progress.
Connecting centres, comparing practice: The role of benchmarking in interventional oncology
CIRSE Insider
The IASIOS Benchmarking Subcommittee, chaired by Prof. Miltiadis Krokidis, is advancing interventional oncology by fostering collaboration and data-driven improvement across centres. In this interview, Prof. Krokidis discusses the value of benchmarking for quality assurance, the subcommittee’s early initiatives, and its plans to expand data collection, workshops, and patient-focused measures. He also reflects on his personal motivation and offers guidance for centres considering IASIOS accreditation. Read the full article to learn how benchmarking is shaping continuous progress in interventional oncology.
MIOT International Becomes the First Hospital in India to Receive IASIOS Accreditation
MIOT Hospitals Private Limited in Chennai has become the first hospital in India to receive IASIOS accreditation, joining a select group of centres worldwide recognised for excellence in interventional oncology. This accreditation confirms that MIOT meets international standards for safety, quality, and structured, patient-centred cancer care using minimally invasive, image-guided treatments.
Key to this recognition is MIOT’s multidisciplinary Tumour Board and commitment to collaborative decision-making, evidence-based practice, and continuous improvement. With a strong focus on innovation and clinical outcomes, MIOT sets a new benchmark for interventional oncology services in India.
The evolution of interventional oncology: pioneering a new era in cancer care
Volume 1, article number 1, (2025)
In this editorial, Philippe L. Pereira and Thomas Helmberger trace the evolution of interventional oncology from a subspecialty of interventional radiology to a recognised fourth pillar of cancer care. They discuss the field’s rapid progress, its growing role in multidisciplinary treatment, and emerging synergies with immunotherapy. The article also highlights IASIOS accreditation as a key element in ensuring standardised, high-quality care across institutions, helping to establish shared benchmarks and strengthen IO’s role within the wider oncology community.
Advancing interventional oncology practice through collaborative learning
CIRSE Insider
The IASIOS Educational Subcommittee, led by Prof. Marco Calandri, is advancing interventional oncology through team-based learning and peer exchange. At ECIO 2025, the first IASIOS Workshop for Radiographers and Nurses highlighted best practices in IO care, from follow-up to intraprocedural teamwork. New initiatives include a communication course for tumour board meetings to strengthen IO’s role in multidisciplinary care. Prof. Calandri also reflects on how IASIOS accreditation has brought his team closer and improved internal processes.
Read the full article to learn more.
Championing IR in patient care: insights from CIRSE president Professor Philippe L. Pereira
Hospital Healthcare Europe
In this interview, CIRSE president Philippe L. Pereira discusses the growth of interventional radiology, the need for better training pathways, and the importance of multidisciplinary collaboration. He highlights IASIOS accreditation as a key step in ensuring high-quality interventional oncology services, recognizing hospitals that integrate patient-centred care with advanced, minimally invasive treatments.
IASIOS announces enrolment of first paediatric centre
Interventional News
St. Jude Children’s Research Hospital is the first pediatric center to seek IASIOS accreditation, setting a new standard in pediatric interventional oncology. IASIOS provides a framework for standardizing patient pathways and ensuring high-quality, safe IO treatments. Led by Michael Temple, St. Jude’s accreditation effort reflects its commitment to advancing paediatric IO and joining a global network dedicated to improving practices and raising awareness.
CIRSE Clinical Practice Survey: Patient safety and quality improvement in IR
Interventional News
In this article, Andreas Mahnken (University Hospital Marburg, Germany) highlights key findings from the CIRSE Clinical Practice Survey on patient safety and quality improvement in interventional radiology. The survey revealed strong engagement, with over half of respondents having direct patient access, 77.3% using safety checklists, and 68.1% participating in quality improvement activities. CIRSE is using these insights to enhance clinical practice support, including through the International Accreditation System for Interventional Oncology Services (IASIOS).
The University Hospital of Strasbourg becomes the world’s first IASIOS Centre of Excellence!
CIRSE Insider
The University Hospital of Strasbourg has become the world’s first IASIOS Centre of Excellence, setting a new benchmark in interventional oncology accreditation. In this article, key figures such as Prof. Afshin Gangi and Dr. Roberto Cazzato share how the IASIOS accreditation process has improved patient care, quality assessments, and team collaboration. From streamlining patient records to enhancing peer discussions and gathering patient feedback, their journey highlights the tangible benefits of structured quality standards in interventional oncology. Read the full article to learn more.
St. Vincent’s University Hospital Raises the Bar for IO as an IASIOS Enrolled Centre
St. Vincent’s University Hospital (SVUH) has enrolled as an IASIOS Centre, marking a critical step toward achieving full interventional oncology accreditation. The article highlights the hospital’s dedication to standardizing IO services, with insights from Prof. David Brophy, Consultant Diagnostic & Interventional Radiologist, emphasizing the significance of this milestone. SVUH’s participation in the global IASIOS community further enhances its leadership in IO, fostering collaboration and continuous improvement in patient outcomes.
